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Background: Cancer therapies have increased patient survival rates, but side
effects such as cardiotoxicity and neurotoxicity can lead to autonomic nervous and
cardiovascular system dysfunction. This would result in a decrease in parasympathetic
activity and the enhancement of sympathetic activity. Heart rate variability (HRV), which
reflects autonomic modulation, is a valuable physiological tool since it correlates with
cancer-related fatigue, stress, depression, and mortality in patients with cancer.
Objective: This study aimed to analyze the effects of exercise programs on the
autonomic modulation, measured by the HRV of patients with cancer and its survivors.
Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines were followed, and the quality of the articles was assessed with the
Physiotherapy Evidence Database (PEDro) scale. The meta-analysis statistic procedure
was performed by using RevMan software version 5.3.
Results: From the 252 articles found, six studies were included in the review
involving 272 participants aged 30–75 years. Exercise programs had a mean length
of 10.4 ± 4.6 weeks, a frequency of 3 ± 1.4 days/week, and a mean duration of
78 ± 23.9min. In time-domain HRV measures, exercise may increase in the SD of
normal-to-normal intervals [p < 0.00001, with a mean difference (MD) of 12.79ms
from 9.03 to 16.55] and a decreased root mean square of successive R–R interval
differences (p = 0.002, with an MD of 13.08ms from 4.90 to 21.27) in comparison
with control groups (CG). The frequency-domain data reveal that the exercise group
(EG) improve significantly more than the CGs in low frequency [absolute power: p
< 0.0001, with a standardized mean difference (SMD) of 0.97 from 0.61 to 1.34;
relative power: p = 0.04, with an MD = −7.70 from −15.4 to −0.36], high-frequency
[absolute power: p = 0.001, with a SMD of 1.49 from 0.32 to 2.66; relative power:
p = 0.04, with an MD of 8.00 normalized units (n.u.) from 0.20 to 15.80], and
low-to-high frequency ratio (p = 0.007 with an MD of −0.32 from −0.55 to −0.09).
Lavín-Pérez et al. Exercise, Oncology and HRV
Conclusion: Exercise programs could lead to positive effects on the autonomic
modulation of patients with cancer and its survivors. More beneficial changes may
occur with resistance and endurance workouts. However, due to the low number of
interventions performed, further research is needed to substantiate the findings and
to provide additional insights regarding the exercise intensity required to increase the
autonomic modulation of the patient.
Keywords: autonomic modulation, exercise programs, cardiovascular dysfunction, oncology, heart rate variability
INTRODUCTION
Modern advances in cancer therapy have resulted in increased
survival rates. However, patients are frequently affected by
various negative side effects (Miller et al., 2019). In particular,
both the autonomic control impairment and the increased risk
of cardiovascular disease (Lakoski et al., 2015) are suffered by
∼80% (Coumbe and Groarke, 2018) and 42% (Chen et al.,
2012) of the patients, respectively. The autonomic nervous
system (ANS) is the main homeostatic regulatory system of the
body, involved in the etiology and the clinical course of cancer
therapies (Simó et al., 2018). Chemotherapy and radiotherapy
cause cardiotoxicity (Scott et al., 2014) and neurotoxicity (Park
et al., 2013), thereby affecting ANS and cardiovascular function.
The cardiovascular ANS needs to be controlled during the cancer
phases to regulate levels of autonomic dysfunction of patients
(Walsh and Nelson, 2002).
Heart rate variability (HRV) is a noninvasive tool to evaluate
the autonomic modulation of the sinus node in healthy,
cardiac, and noncardiac disease populations (Lombardi and
Stein, 2011). In patients with cancer, HRV is a useful, effective,
and more practical method to assess autonomic dysfunction
than other validated methods, which are more complex to apply
(Guo et al., 2013). HRV measures provide a multidimensional
register of autonomic modulation, including the sympathetic
and parasympathetic modulation of cardiac function (Arab
et al., 2016), which is notably modified in patients with
cancer compared with the healthy population. Studies including
wide sample sizes have found significantly lower values in
the root mean square of successive R–R interval measures
(RMSSD), representing the parasympathetic activity, and the
SD of the interbeat interval of normal sinus beats (SDNN)
(i.e., overall HRV measure) of patients with cancer compared
with the healthy population (De Couck and Gidron, 2013;
Bijoor et al., 2016). Cancer-treating drug therapies induce
cardiac abnormalities, such as heart failure, myocardial ischemia,
myocarditis, hypertension, or arrhythmias, among others (Chang
et al., 2017), detected with HRV even with normal systolic
left ventricular function (Tjeerdsma et al., 1999) with an
overactivation of the sympathetic nervous system (SNS) and a
decrease in the parasympathetic nervous system (PNS) activity
(Coumbe and Groarke, 2018). Consequently, this imbalance,
produced by cancer drugs, may stimulate the hypothalamic-
pituitary-adrenal axis and the endocannabinoid and renin-
angiotensin-aldosterone systems producing an increase in
oxidative stress, chronic inflammation, and atherosclerosis with
a reduction in vasodilation, which affects the health of patients
(Lakoski et al., 2015). Several types of research have focused on
the relationship between the global HRV modifications and the
health of patients with cancer obtaining an inverse correlation
with cancer-related fatigue (Fagundes et al., 2011) and depression
(Giese-Davis et al., 2006). Findings also show the role of HRV to
predict survivorship being higher when the vagal nerve activation
is stimulated (Zhou et al., 2016).
Palma et al. (2020) and Dias Reis et al. (2017) published
a systematic review of supportive therapy modalities that
have been developed to reduce the HRV results. They found
interventions based on music therapy, traditional Chinese
medicine-related treatments, exercise, relaxation, and myofascial
release techniques and concluded that HRV seemed to be
a safe and easily applicable method to assess cancer-related
autonomic dysfunction (Palma et al., 2020). However, not only
the consequences of cancer therapy need to be considered to
improve HRV but also the lifestyles of patients can influence it
negatively (Scott et al., 2014). Thus, a multifactorial intervention
that could modify the physiological changes mentioned earlier
and other health and psychological parameters is crucial to
globally benefit the patients with cancer.
Exercise programs appear to promote physiological changes
leading to reduce the decline of the autonomic modulation
and improving its levels during (Mostarda et al., 2017) and
after cancer treatments (Shin et al., 2016). Scott et al. (2014)
approximated the benefits of aerobic exercise training to the
autonomic modulation of patients with cancer stating that it
may decrease sympathetic tone and increase vagal tone by the
influence of exercise in attenuate cardiovascular abnormalities
as heart failure or coronary artery disease. Aerobic exercise
modifies the renin-angiotensin-aldosterone system (Scott et al.,
2014) and stimulates the hypothalamic-pituitary-adrenal axis
suppressing angiotensin II expression, which promotes the
sympathetic activity of the ANS (Routledge et al., 2010).
Consequently, the stimulation of the hypothalamic-pituitary-
adrenal axis and the endocannabinoid and renin-angiotensin-
aldosterone systems is produced (Arab et al., 2016). Exercise also
upregulates nitric oxide promoting vasodilation (Kingwell, 2000;
Scott et al., 2014) reduces reactive oxygen species induced by
chemotherapy toxicity (Scott et al., 2014). Moreover, regarding
the remaining physiological changes mentioned earlier, exercise
can also decrease chronic inflammation (Gleeson et al., 2011),
improving the immune system and the stimulation of natural
killer cells (Khosravi et al., 2019). Exercise can also reduce
body mass index (BMI) (Thomas et al., 2017), which may be
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correlated to an HRV increase (Arab et al., 2016). Although
exercise may have the potential role to increase HRV, the
results presented by the different interventions developed are
controversial considering all the variables inside HRV. In
this way, this systematic review and meta-analysis aimed to
evaluate the effects of exercise interventions on the autonomic
function of patients with cancer and its survivors analyzing the
measures involved.
METHODS
The Preferred Reporting Items for Systematic Reviews andMeta-
Analyses (PRISMA) guidelines have been followed to develop the
systematic review (Liberati et al., 2009). Before the data extraction
was performed, the study was registered in the International
Prospective Register of Systematic Reviews (PROSPERO) by the
following identification number: CRD42020191041.
Search Strategy
The databases employed for searching the articles were Web of
Science (including studies indexed in the KCI-Korean Journal
Database, MEDLINE, Russian Science Citation Index, SciELO
Citation Index, and PubMed (MEDLINE). The terms used for
the search were as follows: cancer and neoplasms, separated
by OR; and HRV, autonomous nervous function, autonomous
nervous system, separated by OR; and exercise, training, physical
activity, also separated by OR. The only filter employed was the
requirement of being articles written in English or Spanish. The
search was carried out from April 2020 to June 2020.
The articles found were included if they fulfilled the following
criteria: (1) the target population was patients with cancer or
survivors, (2) the program involves any physical exercise, (3)
the investigation assesses and reports any HRV variable, (4) the
study includes at least one control group (CG) whose results are
compared with an exercise group (EG). Moreover, the following
exclusion criteria were set: (1) the article was a review, letter to
the editor, conference abstract, case report, or study protocol, (2)
the study did not evaluate the HRV variables directly after the
intervention, and (3) the studies were completely written in a
language different from English or Spanish.
Risk of Bias Assessment
The analysis of the risk of bias was performed using the
Physiotherapy Evidence Database (PEDro) scale, known as a
valid and reliable instrument to assess eligibility, allocation to
groups, blinding of allocation, and comparison between groups
at baseline and its outcomes (Maher et al., 2003). The leading
reasons for its selection were due to it being the most used in the
scientific area of the Sport Sciences for Health and it is a specific
tool focused on physical therapies (Moseley et al., 2020).
Data Extraction
Participants, Interventions, Comparisons, and Study
Designs Information
The main information of the articles is reported in the
tables and figures in the article and the supplementary data.
Regarding participants, CG and EG baseline parameters
were extracted, such as sample size, mean age, BMI,
physical activity level, cancer type, stage, type of treatment,
and timing. The intervention characteristics included the
length of the program, duration of each session, weekly
frequency, exercise description, intensity, progression, and
adherence. The intervention of the comparison group was
also extracted.
HRV Outcome Measurements
Interventions included an HRV assessment before and after the
intervention. For consistency in measures, participants were laid
in a supine position (Niederer et al., 2013; Dias Reis et al., 2017;
Zhou et al., 2018) or seated in chairs (Shin et al., 2016; Lee
et al., 2018). HRV was recorded for 5min of adequate stationary
sign (Niederer et al., 2013; Lee et al., 2018; Zhou et al., 2018)
with Polar S810© (Niederer et al., 2013), CANS 3000 (Laxtha,
Daejeon, Korea) (Shin et al., 2016), or CheckMyHeart Handheld
HRV (Lee et al., 2018) by using ECG (Zhou et al., 2018). The
spectral analysis from the artifact-free data was performed by
the fast Fourier transformation with the Kubios HRV Analysis
software (Niederer et al., 2013; Dias Reis et al., 2017; Mostarda
et al., 2017; Zhou et al., 2018) or AcqKnowledge (Zhou et al.,
2018). The results of this review include two HRV variables in
the time domain, namely, SDNN and RMSSD. In the frequency
domain, the low-frequency (LF) band, the high-frequency (HF)
band, the ratio of LF-to-HF (LF/HF), and the total power (TP),
calculated as the sum of the energy in very-low-frequency (VLF),
LF, and HF bands, were extracted (Shaffer and Ginsberg, 2017).
The frequency-domain data were reported in absolute units by
using milliseconds squared (ms2) or normalized units (n.u.)
obtained by diving the result between the TP and multiplied
to 100 [i.e., LF or HF/(TP–VLF) × 100] (Task Force of the
European Society of Cardiology the North American Society
of Pacing Electrophysiology, 1996). SDNN and RMSSD were
measured in 1/1,000 s (milliseconds) (Shin et al., 2016), and HF
was recorded from 0.15 to 0.4Hz and LF from 0.04 to 0.15Hz
(Table 3) (Niederer et al., 2013; Shin et al., 2016; Dias Reis et al.,
2017; Mostarda et al., 2017; Zhou et al., 2018).
Statistical Analysis
The analysis was performed with the post-intervention means
and SDs of the EG and the CG collected from the articles.
The meta-analysis statistical tool used was the Review Manager
Software (RevMan software version 5.3) (RevMan, 2014). The
selected method was the inverse variance with random effects
and a 95% CI (Schmidt et al., 2009). Additionally, the I2 model
was used to calculate the heterogeneity of the results. The results
were presented with a standardizedmean difference (SMD) when
the same variable was measured in different units (i.e., ms2 and
log ms2) as occurred with the absolute power variables of HF
and LF. In contrast, the mean difference (MD) was used when
all studies assessed the variable using the same units (n.u. or
ms). According to the Cochrane Handbook for Systematic Reviews
of Intervention, the SMD effects were interpreted as small with
results <0.4, moderate from 0.4 to 0.7, and large >0.7 (Higgins
and Green, 2011).
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FIGURE 1 | Study flow diagram following the preferred reporting items for systematic reviews and meta-analyses guidelines.
RESULTS
Study Selection
About 252 articles were identified in Web of Science (n = 166)
and PubMed (n = 86) scientific databases. Figure 1 shows the
flow diagram where 209 articles were analyzed after removing
the duplicates. Two hundred and three articles were excluded
after reading the title or the abstract (n = 164) or after the full-
text evaluation (n = 39). Therefore, both the systematic review
and the meta-analysis were developed with six studies published
between 2012 and 2018.
Risk of Bias
In the PEDro scale, as Table 1 shows the mean score obtained
was 5, and the external validity was 5, ranging from 4–7 (10 being
the highest possible mark). The five articles assessed positively
reached the external validity (item 1) and the statistic items
(items 10 and 11). However, the internal validity punctuation was
more heterogeneous. None of the evaluated studies met items
5, 6, and 7 related to the blinding process, difficult to fulfill in
sport sciences.
Participants Characteristics
The baseline information of the participants is reported in
Table 2. The total sample size of the systematic review was 272,
out of which 126 were included in the CG and 146 in the EG,
and the sample wasmainly composed of women. The ages ranged
from 30 to 75 years, although most of the participants were older
than 45 years of age. Different types of cancer were included in
this study as follows: three interventions contained only patients
with breast cancer (Shin et al., 2016; Dias Reis et al., 2017;
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TABLE 1 | Risk of bias using the PEDro scale.
Validity External
item
Internal items Statistic items TOTAL score
Study 1 2 3 4 5 6 7 8 9 10 11
Lee et al. (2018) Yes Yes No Yes No No No Yes No Yes Yes 5
Zhou et al. (2018) Yes Yes Yes Yes No No No No Yes Yes Yes 6
Dias Reis et al.
(2017)
Yes No No Yes No No No Yes No Yes Yes 4
Mostarda et al.
(2017)
Yes Yes Yes Yes No No No Yes Yes Yes Yes 7
Shin et al. (2016) Yes No No Yes No No No Yes No Yes Yes 4
Niederer et al.
(2013)
Yes No No Yes No No No Yes No Yes Yes 4
Items: 1, eligibility criteria were specified; 2, subjects were randomly allocated to groups; 3, allocation was concealed; 4, the groups were similar at baseline; 5, there was blinding of all
subjects; 6, there was blinding of all therapists; 7, there was blinding of all assessors; 8, measures of at least one key outcome were obtained from more than 85% of the subjects who
were initially allocated to groups; 9, the intention-to-treat analysis was performed on all subjects who received the treatment; 10, the results of the between-group statistical comparisons
are reported for at least one key outcome; 11, the study provides both point measures and measures of variability for at least one key outcome; total score, each satisfied item (except
the first) contributes 1 point to the total score, yielding a PEDro scale score that can range from 0 to 10.
Mostarda et al., 2017) and two incorporated various types of
cancer such as colorectal, lung, breast, genital, gastrointestinal,
and hematological (Niederer et al., 2013; Lee et al., 2018). One
study contained only nasopharyngeal cancer (Zhou et al., 2018).
The patients participated in the exercise program during the
treatment of cancer drugs (i.e., chemotherapy, radiotherapy, and
hormonotherapy) (Niederer et al., 2013; Shin et al., 2016; Zhou
et al., 2018) or after finishing the treatments (Niederer et al., 2013;
Dias Reis et al., 2017; Mostarda et al., 2017; Lee et al., 2018).
Intervention Characteristics
The exercise interventions included in this review are detailed
in Table 3. The length of the exercise program varied from 4
weeks (Mostarda et al., 2017) to 16 weeks (Niederer et al., 2013),
with one intervention conducted during the entire chemotherapy
cycle of 19 months (Zhou et al., 2018). Participants attended
exercise sessions once per week (Lee et al., 2018), three times
per week (Shin et al., 2016; Dias Reis et al., 2017; Mostarda
et al., 2017), and five times per week (Zhou et al., 2018),
whereas Niederer et al. (2013) suggested patients exercise 3–
5 times per week. Together with the study of Zhou et al.
(2018), their interventions were the only programs that included
an unsupervised exercise element. Sessions lasted from 60 to
120min (Niederer et al., 2013; Lee et al., 2018; Zhou et al., 2018),
with a median of a 70-min exercise (Shin et al., 2016; Dias Reis
et al., 2017; Mostarda et al., 2017).
Two exercise programs were based on oriental exercise
techniques, such as Tai Chi (Zhou et al., 2018) and Qigong (Lee
et al., 2018), including a meditation component. The remaining
interventions involved cardiovascular and resistance training
(Niederer et al., 2013; Shin et al., 2016; Dias Reis et al., 2017;
Mostarda et al., 2017), including the program conducted by
Niederer et al. (2013), where patients were counseled to exercise
following the recommendations of the ACSM Roundtable on
Exercise Guidelines for Cancer Survivors (Schmitz et al., 2010)
and could participate in guided Nordic Walking sessions once
per week. Dias Reis et al. (2017) and Mostarda et al. (2017)
incorporated the cardiovascular cycling of 30min and different
free weight exercises, such as squats, shoulder press, hip flexion,
or French press, among others (Dias Reis et al., 2017; Mostarda
et al., 2017). In contrast, Shin et al. (2016) used circuit training
to develop the sessions combining strength and cardiovascular
exercises and using the rate of perceived exertion (RPE) to
monitor and progress the intensity (Shin et al., 2016).
HRV Results
Most of the studies reported the outcome results after treatment.
However, one study (Lee et al., 2018) only reported the change
from baseline. Therefore, it was excluded from thismeta-analysis.
Other than the study of Niederer et al. (2013), the outcomes of
the EG after cancer treatment were extracted (Niederer et al.,
2013). The results were then divided into time and frequency
domains to present how exercise influences patients with cancer
and survivors in these domains.
Regarding the HRV time-domain measure analysis, in SDNN
EG, there were significant increases compared with the CG
with a p < 0.00001 (MD of 12.79 and a 95% CI from 9.03
to 16.55) (Figure 2). Also, Lee et al. (2018) found significant
differences between groups analyzing the change from baseline
(p = 0.001) (Lee et al., 2018). Participants in the EG also
reached higher increases on RMSSD compared to those in the
CG (p = 0.002 with an MD of 13.08ms and 95% CI from
4.90 to−21.27) (Figure 3).
As for the frequency-domain outcomes, the LF and HF results
were obtained in SMD from the analysis of the absolute power
(ms2 or log ms2), and that in MD, the relative power (n.u.).
Figure 4 shows that LF was significantly increased in the EG
compared to the CG in both analyses. In absolute power, results
had a p-value of <0.0001 and an SMD of 0.97 with a 95% CI
from 0.61 to 1.34, while in n.u., the p-value was 0.04 with an
MD of −7.70 n.u. and a 95% CI from −15.04 to −0.36. The HF
results, which are presented in Figure 5, of the EG in absolute
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TABLE 2 | Baseline characteristics of participants.
Study Design Group N (%
females)


















radiotherapy, and target therapy















RCT CG 57 (21.05%) <30 (12.3%), 30–50
(64.9%), and >50 (22.8%)




EG 57 (33.33%) <30 (22.8%), 30–50
(59.6%), and >50 (17.5%)






CG 9 (100%) 45 ± 7 Breast I, II, and III After treatment:
hormonal therapy,
chemotherapy, and radiotherapy
EG 9 (100%) 48 ± 7.2
Mostarda
et al. (2017)









CG 10 (100%) 49.2 (range, 35–60) Breast 0 (10%), I (20%),















CG 15 (60%) 61.6 ± 10.6 Each group: Gastrointestinal










15 (60%) 59.6 ± 9.4 0, I, and II During treatment:
Chemotherapy 14 and
Radiotherapy1
EG (after) 15 (60%) 60.7 ± 6.7 0, I, and II After treatment
RCT, randomized controlled trial; CG, control group; EG, exercise group.
power measures, were significantly higher than the CG outcomes
(p= 0.001, and an SMD of 1.49 with a 95% CI from 0.32 to 2.66)
and their effects on the relative power units (p = 0.04, and an
MD of 8.00 n.u. with a 95% CI from 0.20 to 15.80). Moreover,
Lee et al. (2018) stated that significant differences in the change
from baseline reveal but not between groups (Lee et al., 2018).
The ratio LF/HF showed significant differences between EG and
CG with a p-value of 0.007 and an MD of −0.32 (95% CI from
−0.55 to −0.09), as represented in Figure 6. Finally, the TP
data was not analyzed by meta-analysis only two studies include
the measure (Niederer et al., 2013; Lee et al., 2018). Niederer
et al. (2013) stated the significant differences in the interaction
between groups (i.e., exercise during treatment group, exercise
after treatment group, and CG) and time (before and after
intervention) with a p-value of 0.025. However, their post-hoc
analysis showed high differences between after treatment group
and the CG (p = 0.012). As for the results of Lee et al. (2018),
the Qigong EG significantly increases TP with a p-value of 0.002
from baseline to after intervention.
DISCUSSION
This systematic review and meta-analysis aimed to evaluate the
effects of exercise interventions in the HRV of cancer patients
and survivors. The data obtained showed significant differences
between the EG and the CG in all the variables analyzed as
follows: SDNN, RMSSD, LF (ms2 and n.u.), HF (ms2 and n.u.),
LF/HF ratio, and TP. Thus, exercise interventions may improve
the autonomic control in patients with cancer and reduce the
risk of autonomic dysfunction of participants. However, some
specifications need to be considered due to the heterogeneity
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TABLE 3 | Characteristics of exercise interventions and heart rate variability (HRV) measurements.




Exercise description HRV measurement and analyses process
Lee et al. (2018) CG 12 weeks Tool: CheckMyHeart Handel HRV ECG
Duration: 5min
Position: seated or lying prone
HRV variables: SDNN, TP, and HF
Analysis information
EG 12 weeks 120min 1 time/week Qigong: standing position,









HRV variables: LF, HF, and LF/HF
Analysis information: AcqKnowledge and
Kubios and relative power and normalized
units computation for frequency variables
EG 60min 5
times/week
Supervised or instructional video
Tai Chi exercise:
Warm up: 10min
Main part: 30min Tai Chi exercise and
10min of breathing and meditation
Relaxation: 10 min
Dias Reis et al.
(2017)
CG 12 weeks Tool: Tachogram
Duration: 5min
Position: supine
HRV variables: SDNN, RMSSD, LF, HF, and
LF/HF
Analysis information: beat-to-beat interval of
iR–R, manually and automatic Kubios
software filter, beat-by-beat sets were
converted to equidistant time series and then
applied the FFT
EG 12 weeks ≈70min 3
times/week
Cardiovascular training: 30min cycle
ergometer (60% VO2max )
Resistance training: free weight
exercise (hip flexion and extension,
shoulder press, free squad, French
triceps press, curved row




CG 4 weeks Tool: Tachogram
Duration: 5min
Position: NR
HRV variables: SDNN, RMSSD LF, HF, LF/HF
Analysis information: beat-to-beat interval of
iR-R, manually and automatic Kubios software
filter, FFT, and normalized units computation
EG 4 weeks 70min 3
times/week
Cardiovascular training: 30min cycle
ergometer (60% VO2max )
Resistance training: squat, shoulder
press, hip flexion, barbell bent over
row, and French press




HRV variables: SDNN, RMSSD, LF, HF, LF/HF
Analysis information: R–R interval (1/1,000 s)
EG 8 weeks 70min 3
times/week
Warm up: 10min gymnastics and
stretching (upper body)
Main exercises: 40min circuit
exercises (Shaking while running in
place, flank, running in place, squat,
walking in place, crunch, step, lunge,
running with open arms, back muscle
exercise)
Intensity control: RPE. Progression
from 9 to 14 RPE




CG 16 weeks Tool: Polar S810
Duration: 5min
Position: supine
HRV variables: TP, HF, LF
Analysis information: FFT, Kubios HRV
Analysis, Biosignal Analysis, and
logarithmic values.







(recommendation 3–5 times per
week, 1 h, at 70–90% of individual
anaerobic threshold, 13–14 RPE) and
the opportunity to participate in a
guided Nordic-Walking training
(1 time/week)
EG (after) 16 weeks
CG, control group; EG, exercise group; NR, not reported; VO2max , maximum oxygen consumption; RPE, the rating of perceived exertion; SDNN, SD of the interbeat interval of normal
sinus beats; RMSSD, root mean square of successive differences between normal heartbeats; LF, low-frequency band; HF, high-frequency band; LF/HF, Ratio of LF-to-HF; TP, Total
Power; FFT, fast Fourier transform.
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FIGURE 2 | Effects of exercise in SDNN (standard deviation of the interbeat interval of normal sinus beats) heart rate variability measure.
FIGURE 3 | Effects of exercise in RMSSD (root mean square of successive differences between normal heartbeats) heart rate variability measure.
FIGURE 4 | Effects of exercise in HF (High Frequency) heart rate variability measure expressed in absolute (ms2) and relative (n.u) power.
of the programs and the physiological implications of the
variables analyzed.
Although we have included all the variables measured in the
HRV, the physiological interpretation of some of these variables
of ANS recording is controversial. Only RMSSD and HF have
been proven to reflect the PNS activity to date (Shaffer and
Ginsberg, 2017), whereas the reflection of SNS or PNS in SDNN,
LF, and LF/HF is not clear. SDNN seems to measure the overall
HRV with the contribution of sympathetic and parasympathetic
modulation, but in the short-term resting recordings, the main
source of the variation could be provided from the SNP (Shaffer
and Ginsberg, 2017). The LF physiological interpretation is still
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FIGURE 5 | Effects of exercise in LF (Low Frequency) heart rate variability measure expressed in absolute (ms2) and relative (n.u) power.
FIGURE 6 | Effects of exercise in Ratio HF/LF (ratio of Low Frequency to High Frequency) heart rate variability measure.
not universally agreed since some researchers assume it as an
index of cardiac sympathetic control (Reyes Del Paso et al., 2013),
whereas more current literature state that it may principally
reflect the baroreflex activity (Goldstein et al., 2011) or even being
mainly determined by the PSN (Reyes Del Paso et al., 2013).
However, it seems to depend on the band recording frequency
having a possible SNS implication if it reaches 0.1Hz (Shaffer and
Ginsberg, 2017). Consequently, the physiological interpretation
of the LF/HF ratio is also uncertain due to LF not being a pure
SNS index (Goldstein et al., 2011; Shaffer and Ginsberg, 2017).
With this in mind, the following discussion will be focused on
the HF and RMSSD physiological values to argue the overall
autonomic control effects.
In line with HRV parasympathetic activity variables of
the CGs, several articles have revealed the effects of cancer
treatments in RMSSD and HF and the overall measure of
SDNN. Surgery, for instance, significantly reduces RMSSD
and SDNN even 14 days post-op (Hansen et al., 2013),
which is similar to what occurs after administration of a
high dose of chemotherapy and its subsequent cardiotoxicity
(Kloter et al., 2018). This ANS dysfunction reduces the release
of catecholamine neurotransmitters, which could negatively
influence the regulation of the tumor microenvironment (Hanns
et al., 2019). Cancer decreases catecholamine production, with
a concomitant rise in oxidative stress, inflammation, and cancer
progression (Cole et al., 2015). Under normal conditions, the
PNS could regulate the inflammatory response, but the decline
of the vagal nerve activity produced by cancer may inhibit
inflammatory regulation (Williams et al., 2019). In this way, in
contrast to healthy controls with similar characteristics, patients
with breast cancer have significantly lower RMSSD, HF, and
SDNN values 1 year after treatment (Caro-Morán et al., 2016).
Consequently, when comparing the HRV results with the normal
values of healthy individuals, the differences are notable (Nunan
et al., 2010). Thus, the role of PNS and its variance is so crucial
in cancer prognosis that having a high HF power is positively
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FIGURE 7 | Explication of the changes in the heart rate variability of cancer patients and exercise training effects in comparation to healthy population data. Healthy
population of HRV data from Nunan et al. (2010), cancer and treatments consequences and exercise effects data correspond to control and exercise group after
intervention results of the current systematic review. References from the physiological changes in cancer patients and its exercise effects are reported in the
systematic review discussion. SDNN, standard deviation of the interbeat interval of normal sinus beats; RMSSD, root mean square of successive RR interval
measures; HF, high frequency; LF, low frequency; LF/HF, low-to-high frequency ratio; PNS, parasympathetic nervous system; ROS, reactive oxygen species.
correlated with survival in patients with advanced breast cancer
(Giese-Davis et al., 2015).
Exercise seems to have a positive influence on the ANS of
patients with cancer and its related physiological consequences,
as shown in Figure 7, illustrates, in this case, the recovery to
the normal values of HRV measures after the interventions.
Exercise can induce the increase of catecholamines, which are
commonly reduced due to cancer and lead to positive changes in
tumor hypoxia, angiogenesis, metabolic stress, and cell immunity
(Hojman et al., 2018) by the lactate production, according to
the Warburg effect (San-Millán and Brooks, 2016). This would
increase the parasympathetic responses and decrease the local
oxidative stress and DNA damage, i.e., inflammatory reactions
(De Couck et al., 2012). Consequently, the ability of cancer
cells to form tumors in distinct tissues (Hojman et al., 2018)
and the risk of developing metabolic abnormalities (Licht et al.,
2010) related to poor cancer prognosis (De Couck et al., 2012)
could be reduced. Moreover, exercise may also benefit patients by
increasing the vagal nerve stimulation in the renin-angiotensin-
aldosterone system (Miller and Arnold, 2019). When this occurs,
there may be a reduction in the renin enzyme production (Cunha
et al., 2016), with subsequent angiotensin II reduction, thereby
affecting the cholinergic parasympathetic neurotransmission
to the heart (Miller and Arnold, 2019). These mechanisms
control angiogenesis, tumorigenesis, metastasis, and cellular
proliferation (Munro et al., 2017). Few articles relate the effects
of exercise in the renin-angiotensin-aldosterone of patients with
cancer, but in other disease populations, it appears that exercise
could prevent the increase of angiotensin-converting enzyme and
plasma angiotensin II levels (Nunes-Silva et al., 2017) (Figure 7).
The type of exercise and the intensity of exercise could
be the important factors to consider for the PNS activation.
First, to increase catecholamine production, moderate- or high-
intensity exercise is needed (Zouhal et al., 2008). Additionally,
in HF values, no significant differences between the control
and the Qigong group were found (Lee et al., 2018), and
the Tai Chi intervention presented the lowest MDs results
(Zhou et al., 2018), which could mean that the intensity
performed was too low to impact the PNS activity. Accordingly,
low responses were also shown in the intervention in the
study of Niederer et al. (2013), where participants engaged in
unsupervised physical activity without a structured program
(36). Still, studies carried out with other target populations
show that low-intensity exercise modalities such as Tai Chi
increased the parasympathetic stimulation (Cole et al., 2016).
However, a study with elderly women, which compared the
effects of the autonomic modulation of Tai Chi and walking
programs, found no significant HRV differences between the
groups (Audette et al., 2006). Perhaps higher intensities may
be needed to increase the muscle recruitment associated with
the rise in circulating catecholamines (Spiering et al., 2008),
which has been shown to decrease HRV (Zouhal et al., 2008).
Moreover, the comparison between the effects of endurance
training and resistance training on the autonomic modulation,
measured by HRV, is still controversial in patients with chronic
diseases (Boudet et al., 2017). Although endurance training
Frontiers in Psychology | www.frontiersin.org 10 August 2021 | Volume 12 | Article 712823
Lavín-Pérez et al. Exercise, Oncology and HRV
seemed to be more effective in modifying the HRV activity
in healthy populations, in patients with metabolic syndrome,
the high-intensity resistance training together with endurance
seemed to have greater decreases in the heart rate and greater
increases in the VLF domain compared with moderate resistance
training with endurance workout (Boudet et al., 2017). These
improvements could be produced by the role of strength training
in declining the inflammatory process, an aspect shared with
cancer physiology (Gleeson et al., 2011). Besides, resistance
training may be utilized to prevent or to regain the decline of
HRV considering that sarcopenia is a significant predictor of
toxicity and time to tumor progression (Prado et al., 2009). More
investigation is needed to identify the type of optimal exercise
and to analyze the physiological process of resistance exercise in
HRV physiology.
Most of the sport science investigations performed about HRV
measure the effects of acute doses of exercise during the practice
and in the recovery phase. In cancer, the acute effects of exercise
have been analyzed with HF and RMSSD measures during and
after yoga practice obtaining significant HF alterations in all
the positions performed except in meditation and post-resting
(Mackenzie et al., 2014). Hence, in line with the previous
literature, a higher muscle activation may be required during
exercise to stimulate the vagal nerve activity. An intervention
carried out with Tai Chi Qigong added that a minimum of
4min of practice is required to achieve the effects in HF and
LF (Fong et al., 2015). Moreover, HRV measures could provide
an opportunity to record how participants have responded to
training in the 12–24 h post-exercise session (Javaloyes et al.,
2020). These HRV outcomes, usually measured by RMSSD,
can guide to decide the intensity and volume of the following
session of training (Kiviniemi et al., 2007; Javaloyes et al., 2020).
Nevertheless, no investigations have been performed at present
with patients with cancer.
The current meta-analysis and systematic review are the first
to explore the effects of exercise programs on the HRV of patients
with cancer and its survivors. Some limitations need to be
mentioned. The total sample size was moderate at best, although
interventions that involved all types of exercise were included.
Consequently, the studies analyzed were heterogeneous, limiting
the generalization of the results, but still provide a wider review
of the types of interventions investigated in the field. Finally, only
studies written in English or Spanish, indexed in PubMed orWeb
of Science and articles with a before and after HRV measure or
changes from baseline outcomes were included.
CONCLUSION
Exercise programs may lead to positive effects on the overall
autonomic control, measured byHRVof patients with cancer and
its survivors. This systematic review and meta-analysis show that
exercise can increase SDNN (overall HRV), RMSSD, andHF (n.u.
andms2), reflecting the stimulation of PNS activity. Furthermore,
significant differences between EG and CGwere also found in the
LF and the LF/HF ratio of HRV variables. Due to the low number
of interventions performed on HRV, exercise, and cancer, no
further conclusions can be made. Thus, future research is needed
to contrast the findings and to provide more specific information
about the type and intensity of exercise required to improve the
overall autonomic control and to reduce the toxicity and future
autonomic dysfunction of the patient with cancer.
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